Surgical Castration in Hormone-Refractory Metastatic Prostate Cancer Patients Can Be an Alternative for Medical Castration

Background. Most patients with metastatic prostate cancer are endocrinologically treated with LHRH agonist, but finally castration-refractory and hormone-refractory cancers occur. Serum testosterone levels get low to “the castration level” by LHRH agonists but may not get low enough against castrati...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaitsu, Masayoshi, Yamanoi, Mariko, Mikami, Koji, Takeshima, Yuta, Okamoto, Naohiko, Imao, Sadao, Tonooka, Akiko, Takeuchi, Takumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130489/
https://www.ncbi.nlm.nih.gov/pubmed/21754927
http://dx.doi.org/10.1155/2012/979154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3130489/
https://www.ncbi.nlm.nih.gov/pubmed/21754927
http://dx.doi.org/10.1155/2012/979154

Ejemplares similares